7 Biotech Giants Pushing the Envelope in Trispecific Antibodies
The advancement of trispecific antibodies is opening new doors in the field of cancer treatment. Unlike traditional monoclonal or bispecific antibodies, these novel agents are capable of engaging three distinct targets, which enhances immune cell activation and tumor cell recognition. As a result, trispecifics offer the potential for greater therapeutic precision and improved clinical...
0 Commentaires
0 parts